[go: up one dir, main page]

FR2625099B1 - PROTEINS AND THEIR PREPARATION METHOD, DNA SEQUENCES, ANTIBODIES AND THEIR APPLICATION, POXVIRUSES, TRANSFORMED OR INFECTED CELLS AND PHARMACEUTICAL COMPOSITIONS USEFUL IN THE PREVENTION OF TOXOPLASMOSIS - Google Patents

PROTEINS AND THEIR PREPARATION METHOD, DNA SEQUENCES, ANTIBODIES AND THEIR APPLICATION, POXVIRUSES, TRANSFORMED OR INFECTED CELLS AND PHARMACEUTICAL COMPOSITIONS USEFUL IN THE PREVENTION OF TOXOPLASMOSIS

Info

Publication number
FR2625099B1
FR2625099B1 FR8718180A FR8718180A FR2625099B1 FR 2625099 B1 FR2625099 B1 FR 2625099B1 FR 8718180 A FR8718180 A FR 8718180A FR 8718180 A FR8718180 A FR 8718180A FR 2625099 B1 FR2625099 B1 FR 2625099B1
Authority
FR
France
Prior art keywords
poxviruses
toxoplasmosis
antibodies
proteins
transformed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR8718180A
Other languages
French (fr)
Other versions
FR2625099A1 (en
Inventor
Guy Bruno
Marie-France Cesbron
Jean-Pierre Lecocq
Andre Capron
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Transgene SA
Original Assignee
Transgene SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene SA filed Critical Transgene SA
Priority to FR8718180A priority Critical patent/FR2625099B1/en
Priority to JP1500776A priority patent/JPH02502878A/en
Priority to EP89900842A priority patent/EP0346430A1/en
Priority to PCT/FR1988/000640 priority patent/WO1989005658A1/en
Publication of FR2625099A1 publication Critical patent/FR2625099A1/en
Application granted granted Critical
Publication of FR2625099B1 publication Critical patent/FR2625099B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/45—Toxoplasma
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/55—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FR8718180A 1987-12-24 1987-12-24 PROTEINS AND THEIR PREPARATION METHOD, DNA SEQUENCES, ANTIBODIES AND THEIR APPLICATION, POXVIRUSES, TRANSFORMED OR INFECTED CELLS AND PHARMACEUTICAL COMPOSITIONS USEFUL IN THE PREVENTION OF TOXOPLASMOSIS Expired - Fee Related FR2625099B1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR8718180A FR2625099B1 (en) 1987-12-24 1987-12-24 PROTEINS AND THEIR PREPARATION METHOD, DNA SEQUENCES, ANTIBODIES AND THEIR APPLICATION, POXVIRUSES, TRANSFORMED OR INFECTED CELLS AND PHARMACEUTICAL COMPOSITIONS USEFUL IN THE PREVENTION OF TOXOPLASMOSIS
JP1500776A JPH02502878A (en) 1987-12-24 1988-12-23 Proteins and their production methods, DNA sequences, antibodies and their applications, poxviruses, transformed or infected cells and pharmaceutical formulations useful for the prevention of toxoplasmosis.
EP89900842A EP0346430A1 (en) 1987-12-24 1988-12-23 Proteins and process for preparing them, dna sequences, antibodies and their application, poxvirus, transformed or infected cells and pharmaceutical compositions useful for preventing toxoplasmosis
PCT/FR1988/000640 WO1989005658A1 (en) 1987-12-24 1988-12-23 Proteins and process for preparing them, dna sequences, antibodies and their application, poxvirus, transformed or infected cells and pharmaceutical compositions useful for preventing toxoplasmosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8718180A FR2625099B1 (en) 1987-12-24 1987-12-24 PROTEINS AND THEIR PREPARATION METHOD, DNA SEQUENCES, ANTIBODIES AND THEIR APPLICATION, POXVIRUSES, TRANSFORMED OR INFECTED CELLS AND PHARMACEUTICAL COMPOSITIONS USEFUL IN THE PREVENTION OF TOXOPLASMOSIS

Publications (2)

Publication Number Publication Date
FR2625099A1 FR2625099A1 (en) 1989-06-30
FR2625099B1 true FR2625099B1 (en) 1991-06-14

Family

ID=9358323

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8718180A Expired - Fee Related FR2625099B1 (en) 1987-12-24 1987-12-24 PROTEINS AND THEIR PREPARATION METHOD, DNA SEQUENCES, ANTIBODIES AND THEIR APPLICATION, POXVIRUSES, TRANSFORMED OR INFECTED CELLS AND PHARMACEUTICAL COMPOSITIONS USEFUL IN THE PREVENTION OF TOXOPLASMOSIS

Country Status (4)

Country Link
EP (1) EP0346430A1 (en)
JP (1) JPH02502878A (en)
FR (1) FR2625099B1 (en)
WO (1) WO1989005658A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3940598A1 (en) * 1989-12-08 1991-06-13 Behringwerke Ag TOXOPLASMA GONDII-ANTIGENE, THEIR PRODUCTION AND USE
JPH02261382A (en) * 1989-04-03 1990-10-24 Mochida Pharmaceut Co Ltd Novel dna sequence originated from toxoplasma and protein coded therewith
US5578453A (en) * 1990-08-10 1996-11-26 The Flinders University Of South Australia Cloning and expression of toxoplasma antigens and use of recombinant antigens
FR2714074B1 (en) * 1993-12-20 1996-03-01 Pasteur Institut Promoters of the GRA1, GRA2, GRA5 and GRA6 genes of toxoplasma gondii and expression vectors comprising said promoters.
ZA958366B (en) * 1994-10-06 1996-04-24 Akzo Nobel Nv New toxoplasma gondii antigens
EP0953641A3 (en) * 1998-03-26 2002-03-13 Pfizer Products Inc. Polynucleotide molecules encoding neospora proteins
DE602006013428D1 (en) 2005-03-08 2010-05-20 Sigma Tau Ind Farmaceuti CHIMAIR RECOMBINANT ANTIGENS OF TOXOPLASMA GONDII
CN103517714A (en) * 2010-12-23 2014-01-15 英珀特疗法有限公司 Methods and compositions of protein antigens for the diagnosis and treatment of toxoplasma gondii infections and toxoplasmosis
US9915662B2 (en) * 2012-07-23 2018-03-13 Sylvie Hermouet Protein microarray for characterizing the specificity of the monoclonal immunoglobulins of MGUS or myeloma patients
FR2994482B1 (en) * 2012-08-13 2014-08-22 Repropharm COMPOSITION, METHOD AND KIT FOR DETECTION OF PREVULATORY PIC OF LH

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2518407A1 (en) * 1981-12-17 1983-06-24 Merieux Inst NOVEL ANTIGEN FOR THE RESEARCH OF TOXOPLASMIC IMMUNITY AND ITS PREPARATION METHOD
US4564592A (en) * 1983-01-21 1986-01-14 Research Corporation Toxoplasmosis factor and production of same
FR2564731B1 (en) * 1984-05-28 1986-10-10 Ambroise Thomas Pierre NOVEL TOXOPLASMIC EXO-ANTIGENIC FRACTIONS, THEIR PREPARATION PROCESS AND THEIR APPLICATION TO THE RESEARCH OF TOXOPLASMIC IMMUNITY IN MAN BY SKIN TESTS
AU613583B2 (en) * 1986-08-22 1991-08-08 Transgene S.A. Proteins and the method for preparing them, DNA sequences, antibodies and their application, poxviruses, transformed or infected cells, pharmaceutical compositions which are useful in the prevention of schistosomiasis and application by way of an agent possessing glutathione s-transferase activity

Also Published As

Publication number Publication date
FR2625099A1 (en) 1989-06-30
JPH02502878A (en) 1990-09-13
WO1989005658A1 (en) 1989-06-29
EP0346430A1 (en) 1989-12-20

Similar Documents

Publication Publication Date Title
FI904092A7 (en) Pharmaceutical preparations for the treatment of severe pain conditions and method for their preparation
BE880201A (en) PURIFIED PROTEINS, METHOD OF PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DE3685094D1 (en) PHARMACEUTICAL PREPARATION FOR THE CONTROLLED RELEASE OF ACTIVE SUBSTANCES.
PT82575A (en) PROCESS FOR THE PREPARATION OF A CONJUGATE PRODUCT CONSISTING OF AN S.MUTANS ADHESIN OF A PROTEIN NATURE OF A COMPOSITION WITH IMMUNOGEN ACTIVITY AND AN S.MUTANS POLYSACCHARIDE AND USE THEREOF PARTICULARLY IN ANTI-CARIES VACCINES
DE3875667D1 (en) HUMAN PAPILLOMAVIRUS NUCLEIC ACID SAMPLES.
RU93033479A (en) METHOD FOR OBTAINING SUBSTITUTED PYRROLES, METHOD FOR OBTAINING PHARMACEUTICAL PREPARATIONS
IT8548445A0 (en) PHARMACEUTICAL COMPOSITION AND SLOW RELEASE AND METHOD FOR ITS PREPARATION
IT1240605B (en) SOLID PHARMACEUTICAL COMPOSITION AND PROCEDURE FOR ITS PREPARATION
DE3787377D1 (en) APPLICATION-ENHANCING AGENTS FOR TRANSDERMAL ADMINISTRATION OF SYSTEMIC AGENTS.
FR2738151B1 (en) ANTAGONISTS OF THE ONCOGENIC ACTIVITY OF THE MDM2 PROTEIN, AND THEIR USE IN THE TREATMENT OF CANCERS
AU597698B2 (en) Expression products of human papilloma virus type 18, antibodies specific to these proteins, and diagnostic aids containing these antibodies or corresponding DNA
FR2625099B1 (en) PROTEINS AND THEIR PREPARATION METHOD, DNA SEQUENCES, ANTIBODIES AND THEIR APPLICATION, POXVIRUSES, TRANSFORMED OR INFECTED CELLS AND PHARMACEUTICAL COMPOSITIONS USEFUL IN THE PREVENTION OF TOXOPLASMOSIS
FI882746A7 (en) Hybrid protein C and method for its preparation.
FI893724A7 (en) Hybrid protein C structures and methods for their preparation
IT8922164A0 (en) PHARMACEUTICAL COMPOSITION AND PROCEDURE FOR ITS PREPARATION
FR2598420B1 (en) NOVEL RETINOIC ANTIBIOTICS ESTERS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM
FR2605004B1 (en) NOVEL AMINO ACID DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
FR2580632B1 (en) CYCLOPENTILIC ETHERS, THEIR PREPARATION AND PHARMACEUTICAL FORMULATION CONTAINING THEM
FR2602771B1 (en) NOVEL BENZYL-4 PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
EP0268640A4 (en) VACCINE STIMULATING OR IMPROVING THE PRODUCTION OF ANTIBODIES AGAINST GM2.
FR2616152B1 (en) NOVEL POLYSILANES, CORRESPONDING MODIFIED POLYSILANES, THEIR PREPARATION AND THEIR APPLICATION IN CROSS-LINKABLE COMPOSITIONS
PT84933B (en) PROCESS FOR THE PREPARATION OF CYCLODEPSIPEPTIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
MA20440A1 (en) CARBOXYLIC ACIDS CARRYING A RADICAL BENZOXAZOLYLAMINO OR BENZOTHIAZOLYLAMINO, THEIR PREPARATION AND THEIR APPLICATION IN POLYTOSANITARY PRODUCTS
FR2631829B1 (en) FUNGAL EXOPOLYSACCHARIDES HAVING IMMUNOSTIMULANT ACTIVITY, PROCESS FOR OBTAINING SAME AND THERAPEUTIC COMPOSITION CONTAINING THEM
FR2603040B1 (en) PROTEIN, DNA SEQUENCE, POXVIRUSES, CELLS AND THEIR CULTURE PROCESS, AS WELL AS THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, USEFUL IN THE PREVENTION OF SCHISTOSOMOSIS

Legal Events

Date Code Title Description
ST Notification of lapse